Celularity Inc.
Business hours
| Monday | 12:00am to 12:00am |
| Tuesday | 12:00am to 12:00am |
| Wednesday | 12:00am to 12:00am |
| Thursday | 12:00am to 12:00am |
| Friday | 12:00am to 12:00am |
| Saturday | 12:00am to 12:00am |
| Sunday | 12:00am to 12:00am |
About us
Celularity, Inc. (Nasdaq: CELU) headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by developing off-the-shelf placental-derived allogeneic cell therapies, including unmodified natural killer (NK) cells, genetically-modified NK cells, T-cells engineered with a CAR (CAR T-cells), and mesenchymal-like adherent stromal cells (ASCs) targeting indications across cancer, infectious and degenerative diseases. In addition, Celularity develops and manufactures innovative biomaterials also derived from the postpartum placenta. Celularity believes that by harnessing the placenta's unique biology and ready availability, it will be able to develop therapeutic solutions that address significant unmet global needs for effective, accessible, and affordable therapies.